Which lens gives sharper sight after cataracts? new trial aims to find out

NCT ID NCT07165197

Recruiting now Symptom relief Sponsor: OMIQ Research Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two types of advanced lens implants (Clareon Vivity and PureSee) used in cataract surgery. Researchers want to see which lens provides better vision at far, intermediate, and near distances. The trial involves 80 adults aged 50 and older who need cataract surgery in both eyes. Participants will receive one lens type in each eye, and their vision will be tested over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: extended depth of focus intraocular lenses (Clareon Vivity and PureSee)
What this could lead to: If successful, this study could help doctors choose the best lens for cataract patients, potentially improving vision at multiple distances without glasses.
What could go wrong: This is a small, early-stage trial with only 80 participants, so results may not apply to everyone. Individual outcomes can vary, and not all patients may achieve perfect vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract senile cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Locations

OMIQ Research
RECRUITING

Sant Cugat del Vallès, Barcelona, 08195, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.